IMMUTEP LTD (PRRUF:OTCMKTS)
$0.0306 0 (0%)
Analysed IMMUTEP LTD (PRRUF:OTCMKTS) News Sources
Immutep Provides Clinical Update in 1st line NSCLC: Positive Mature Overall Survival Data from INSIGHT-003 and Update from TACTI-004
13-07-2026
yahoo.com
Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor
14-07-2026
yahoo.com
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
21-07-2026
yahoo.com
Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026
24-07-2026
yahoo.com
Immutep Quarterly Activities Report Q4 FY26
30-07-2026
yahoo.com
Immutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)
11-09-2026
yahoo.com
Change to American Depositary Share Ratio
21-09-2026
yahoo.com
Immutep Receives ~A$0.86 Million R&D Tax Incentive
30-09-2026
yahoo.com
Immutep Regains Compliance with Nasdaq Minimum Bid Price Requirement
13-10-2026
yahoo.com
Immutep and Monash University Secure Further ARC Linkage Projects Funding for LAG-3 Research
14-10-2026
yahoo.com
What is the current price of IMMUTEP LTD (PRRUF:OTCMKTS)?
The current price of IMMUTEP LTD (PRRUF:OTCMKTS) is $0.0306.
IMMUTEP LTD (PRRUF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of IMMUTEP LTD (PRRUF:OTCMKTS) since the previous trading day is $0.
IMMUTEP LTD (PRRUF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of IMMUTEP LTD (PRRUF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for IMMUTEP LTD (PRRUF:OTCMKTS)?
The most recent average sentiment score for IMMUTEP LTD (PRRUF:OTCMKTS) is 66 out of 100.
What is the most recent average sentiment for IMMUTEP LTD (PRRUF:OTCMKTS)?
The most recent sentiment for IMMUTEP LTD (PRRUF:OTCMKTS) is .
SEC-8K** Filing Available For IMMUTEP LTD (PRRUF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.